These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6811103)

  • 1. Antagonizing effect of lithium on the development of dopamine supersensitivity in the tuberoinfundibular system.
    Tanimoto K; Maeda K; Chihara K
    Brain Res; 1982 Aug; 245(1):163-6. PubMed ID: 6811103
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of lithium on hypothalamic-pituitary dopaminergic function.
    Lal S; Nair NP; Guyda H
    Acta Psychiatr Scand; 1978 Jan; 57(1):91-6. PubMed ID: 636903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition by lithium of dopamine receptors in rat prolactin release.
    Tanimoto K; Maeda K; Chihara K
    Brain Res; 1981 Nov; 223(2):335-42. PubMed ID: 6269703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lithium does not interact with haloperidol in the dopaminergic pathways of the rat brain.
    Reches A; Jackson-Lewis V; Fahn S
    Psychopharmacology (Berl); 1984; 82(4):330-4. PubMed ID: 6427824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulating role of lithium on dopamine turnover, prolactin release, and behavioral supersensitivity following haloperidol and reserpine.
    McIntyre IM; Kuhn C; Demitriou S; Fucek FR; Stanley M
    Psychopharmacology (Berl); 1983; 81(2):150-4. PubMed ID: 6415746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of chronic lithium on behavioral and biochemical indices of dopamine receptor supersensitivity in the rat.
    Pittman KJ; Jakubovic A; Fibiger HC
    Psychopharmacology (Berl); 1984; 82(4):371-7. PubMed ID: 6427831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium dissociates haloperidol-induced behavioral supersensitivity from reduced dopac increase in rat striatum.
    Meller E; Friedman E
    Eur J Pharmacol; 1981 Nov; 76(1):25-9. PubMed ID: 7318921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence of low hypothalamic dopaminergic activity after removal of chronic estrogen treatment.
    Gottschall PE; Sarkar DK; Meites J
    Proc Soc Exp Biol Med; 1986 Jan; 181(1):78-86. PubMed ID: 3945627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of dopaminergic supersensitivity after a single dose of the neuroleptic isofloxythepin.
    Valchár M; Metysová J; Chlebounová J; Dlabac A
    Psychopharmacology (Berl); 1982; 76(4):381-4. PubMed ID: 6126896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. I. Locomotor activity and behavioral supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Bloom FE
    Brain Res; 1982 Jan; 232(2):391-400. PubMed ID: 6322914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lithium effects on estrogen-induced dopaminergic supersensitivity in rats.
    Dorce VA; Palermo-Neto J
    Brain Res Bull; 1992 Aug; 29(2):239-41. PubMed ID: 1525677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of dopamine from tuberoinfundibular neurons into pituitary stalk blood after prolactin or haloperidol administration.
    Gudelsky GA; Porter JC
    Endocrinology; 1980 Feb; 106(2):526-9. PubMed ID: 7353525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium effects on haloperidol-induced pre- and postsynaptic dopamine receptor supersensitivity.
    Verimer T; Goodale DB; Long JP; Flynn JR
    J Pharm Pharmacol; 1980 Sep; 32(9):665-6. PubMed ID: 6107377
    [No Abstract]   [Full Text] [Related]  

  • 15. Influence of lithium on biochemical manifestations of striatal dopamine target cell supersensitivity induced by prolonged haloperidol treatment.
    Le Douarin C; Oblin A; Fage D; Scatton B
    Eur J Pharmacol; 1983 Sep; 93(1-2):55-62. PubMed ID: 6628547
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new animal model of dopamine supersensitivity using s.c. implantation of haloperidol releasing polymers.
    Köhler U; Schröder H; Augustin W; Sabel BA
    Neurosci Lett; 1994 Mar; 170(1):99-102. PubMed ID: 8041522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haloperidol-induced presynaptic dopamine supersensitivity is blocked by chronic lithium.
    Gallager DW; Pert A; Bunney WE
    Nature; 1978 May; 273(5660):309-12. PubMed ID: 652037
    [No Abstract]   [Full Text] [Related]  

  • 18. Adenohypophysial dopamine content and prolactin secretion in the aged male and female rat.
    Demarest KT; Moore KE; Riegle GD
    Endocrinology; 1985 Apr; 116(4):1316-23. PubMed ID: 3971917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of lithium treatment on the activity of central dopaminergic neurons].
    Koyama T
    Hokkaido Igaku Zasshi; 1987 May; 62(3):402-16. PubMed ID: 3111963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-dependent increase in plasma prolactin after pituitary stalk section: role of posterior pituitary dopamine.
    Murai I; Garris PA; Ben-Jonathan N
    Endocrinology; 1989 May; 124(5):2343-9. PubMed ID: 2495929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.